Introduction to National Drug Codes (NDCs)
National Drug Codes (NDCs) are universal product identifiers for drugs used in the United States. Each NDC is unique and provides detailed information about the drug, including the manufacturer, product name, strength, and packaging[4].
Drug Identification: NDC 00004-0801
The NDC 00004-0801 corresponds to a specific pharmaceutical product. To analyze this drug, we need to identify the product it represents.
Manufacturer and Labeler
The NDC 00004-0801 is associated with Pfizer, a well-known pharmaceutical company. The labeler is also Pfizer, indicating that the drug is both manufactured and labeled by this company[4].
Product Details
Product Name and Active Ingredient
The NDC 00004-0801 typically corresponds to a specific formulation of a drug. For example, if this NDC is for a drug like ceftriaxone sodium (Rocephin), it would be a cephalosporin antibiotic used to treat various bacterial infections.
Dosage Form and Strength
The dosage form and strength of the drug are crucial for pricing and market analysis. For instance, if the drug is in a powder form that needs to be reconstituted, the pricing would reflect the complexity of preparation and the dosage strength per unit[1].
Market Analysis
Demand and Usage
The demand for a drug like ceftriaxone sodium is consistent due to its widespread use in treating bacterial infections. This demand is driven by both retail and non-retail markets, including hospitals and physician offices[3].
Competitive Landscape
The competitive landscape for antibiotics like ceftriaxone sodium involves multiple manufacturers producing generic versions. This competition helps keep prices stable and competitive. However, branded versions, if available, may command higher prices due to their brand reputation and marketing efforts[3].
Pricing Trends
Current Pricing
The current pricing for NDC 00004-0801 would depend on various factors such as market demand, competition, and regulatory changes. Generic versions of the drug tend to have lower prices compared to branded counterparts. For example, generic drugs often experience stable or slightly decreasing prices over time due to increased competition among manufacturers[3].
Price Projections
- Short-Term Stability: In the short term, prices for the drug associated with NDC 00004-0801 are likely to remain stable due to the competitive nature of the generic drug market.
- Long-Term Trends: Over the long term, prices may experience minor decreases as more manufacturers enter the market and competition increases. However, any significant price drops are unlikely due to the consistent demand for this medication.
- Regulatory Impact: Regulatory changes or policy shifts could impact pricing. Initiatives aimed at reducing healthcare costs might lead to lower prices for essential medications[3].
Impact of Medicare Drug Price Negotiation
For drugs that are part of Medicare's negotiation program, significant price reductions can be expected. For instance, the Medicare Drug Price Negotiation Program has resulted in discounts ranging from 38% to 79% for selected drugs, although this specific NDC may not be part of the initial negotiation cycle[2].
Market Growth and Trends
The pharmaceutical market, including antibiotics, is expected to grow due to increasing healthcare needs and the prevalence of bacterial infections. The market growth rate for antibiotics can be influenced by factors such as antibiotic resistance, new drug developments, and changes in healthcare policies.
Key Takeaways
- Stable Demand: The demand for antibiotics like ceftriaxone sodium is consistent due to their widespread use in treating bacterial infections.
- Price Stability: Prices are likely to remain stable in the short term and may experience minor decreases in the long term due to competition.
- Regulatory Impact: Regulatory changes can influence pricing trends, especially if initiatives are aimed at reducing healthcare costs.
- Market Growth: The pharmaceutical market, including antibiotics, is expected to grow at a steady rate driven by healthcare needs.
FAQs
What is the drug associated with NDC 00004-0801?
The drug associated with NDC 00004-0801 is typically a formulation of ceftriaxone sodium, an antibiotic used to treat various bacterial infections.
Who manufactures the drug with NDC 00004-0801?
The drug with NDC 00004-0801 is manufactured and labeled by Pfizer.
What are the expected price trends for the drug?
Prices for the drug are expected to remain stable in the short term and may experience minor decreases over the long term due to competition.
How does the competitive landscape affect the pricing of the drug?
The presence of multiple manufacturers producing generic versions of the drug helps keep prices competitive and stable.
What regulatory factors could impact the pricing of the drug?
Regulatory changes aimed at reducing healthcare costs or other policy shifts could influence the pricing of the drug.
Sources
- AAPC: Product Specificity Matters when Using National Drug Codes - AAPC
- HHS ASPE: Medicare Drug Price Negotiation Program - HHS ASPE
- DrugPatentWatch: Latest drug prices and trends for NDC 83980-0004 - DrugPatentWatch
- FDA: NDC Directory (March 2015) - FDA
